Emails to Company Going Forward, page-39

First 39 Last

Share
Profile

Follow
Cylon

121 Posts.

3

17/12/23

13:38

Post #: 71492905
Share

Originally posted by AusCannOfficial: ↑

Hi All,

I'm not trying to pump the stock that is unlisted nor do I actually care what you do with your holding when it gets relisted. People that know me know I'm certainly not the share police and everyone is entitled to do with their investment as they see fit - this will also apply to me in time as well but for obvious reasons of the size of my investment compared to others means I'll have to wait until the company is fully operational and transitioned from a micro cap to a small cap to a mid cap over time - its the only possible way for me to get out and this will take years of work which I know. I've been here before and will no doubt be here again so its just the process.

I'm on here though as there are 15,000 shareholders who have had very little communication of late and I have come onto the board to push change and get the company aligned, funded and to move it back to a relisting. I will give you factual information only and where someone asks my opinion I'll share that too if I think its worthwhile. I'm not a scientist and I'm not an expert but I have been around this industry for a while now so would consider myself a little more informed than the average person but I won't be right all the time and you will all need to make your own call on what you do with your investment. I know that not everyone will agree with what I say nor like me and that's ok too but it won't change my putting more information out on this forum for shareholders to discuss and debate when it is appropriate to do so.

Andrew.

Expand

your insight/view as to our flagship 'neuvis' is some what different from previous info from ac8. my last impression was 'neuviv' still a goer,, maybe i am incorrect and missing a piece of the puzzle.

interesting find out other share holders views on this topic

AC8 Price at posting: 4.0¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

PL3

Patagonia looks to raise $2.15M for South American exploration and development

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

There are more pages in this discussion • 61 more messages in this thread...

First 39 Last

Add AC8 (ASX) to my watchlist

(20min delay)
Last 4.0¢		Change 0.000(0.00%)		Mkt cap ! $17.62M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Emails to Company Going Forward, page-39

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Patagonia looks to raise $2.15M for South American exploration and development

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Featured News

Featured News

Emails to Company Going Forward, page-39

Top Stories

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Patagonia looks to raise $2.15M for South American exploration and development

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Featured News

Featured News